ursodeoxycholic acid has been researched along with Malignant Melanoma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 3 (75.00) | 2.80 |
Authors | Studies |
---|---|
Li, Y; McWhirter, E; Stewart, L; Tang, S | 1 |
Cresti, N; Dyson, JK; Jones, DEJ; Lambourne, B; Plummer, R; Stuart, L; Turner, P | 1 |
Bando, H; Hosoda, W; Matsubara, Y; Muro, K; Niwa, Y; Onishi, S; Tajika, M | 1 |
Chen, QX; Fu, QR; Huang, ZJ; Lin, JY; Shen, DY; Wang, Q; Yu, H | 1 |
4 other study(ies) available for ursodeoxycholic acid and Malignant Melanoma
Article | Year |
---|---|
Pembrolizumab-induced immune-related sclerosing cholangitis.
Topics: Antibodies, Monoclonal, Humanized; Cholangitis, Sclerosing; Humans; Male; Melanoma; Ursodeoxycholic Acid | 2023 |
Pembrolizumab as a Cause of Cholangiopathy in a Patient With Metastatic Melanoma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Cholagogues and Choleretics; Cholangitis, Sclerosing; Female; Glucocorticoids; Hepatitis; Humans; Liver Function Tests; Melanoma; Middle Aged; Neoplasm Staging; Programmed Cell Death 1 Receptor; Skin Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Ursodeoxycholic Acid | 2020 |
Ursodeoxycholic acid and bezafibrate were useful for steroid-refractory, immune-related hepatitis: a case report.
Topics: Aged; Bezafibrate; Humans; Male; Melanoma; Nivolumab; Skin Neoplasms; Ursodeoxycholic Acid | 2020 |
Apoptosis induced by ursodeoxycholic acid in human melanoma cells through the mitochondrial pathway.
Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Caspase Inhibitors; Caspases; Cell Line, Tumor; Drug Screening Assays, Antitumor; G2 Phase Cell Cycle Checkpoints; Humans; Melanoma; Membrane Potential, Mitochondrial; Microscopy, Electron, Transmission; Mitochondria; Reactive Oxygen Species; Signal Transduction; Skin Neoplasms; Ursodeoxycholic Acid | 2019 |